HAMLET PROTEIN A/S — Credit Rating and Financial Key Figures

HAMLET PROTEIN A/S (CVR number: 16049441K) is a company from HORSENS. The company reported a net sales of 850 mDKK in 2023, demonstrating a decline of -8.3 % compared to the previous year. The operating profit percentage was at 1.6 % (EBIT: 13.5 mDKK), while net earnings were -13.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 2.5 %, which can be considered weak but Return on Equity (ROE) was -27 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 8 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. HAMLET PROTEIN A/S's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.